These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
398 related articles for article (PubMed ID: 34769488)
21. Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice. Zhao C; Liu L; Liu Q; Li F; Zhang L; Zhu F; Shao T; Barve S; Chen Y; Li X; McClain CJ; Feng W Mol Metab; 2019 Nov; 29():145-157. PubMed ID: 31668386 [TBL] [Abstract][Full Text] [Related]
22. ChREBP-Mediated Regulation of Lipid Metabolism: Involvement of the Gut Microbiota, Liver, and Adipose Tissue. Iizuka K; Takao K; Yabe D Front Endocrinol (Lausanne); 2020; 11():587189. PubMed ID: 33343508 [TBL] [Abstract][Full Text] [Related]
23. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. Benhamed F; Denechaud PD; Lemoine M; Robichon C; Moldes M; Bertrand-Michel J; Ratziu V; Serfaty L; Housset C; Capeau J; Girard J; Guillou H; Postic C J Clin Invest; 2012 Jun; 122(6):2176-94. PubMed ID: 22546860 [TBL] [Abstract][Full Text] [Related]
24. Hepatic glucokinase regulatory protein and carbohydrate response element binding protein attenuation reduce de novo lipogenesis but do not mitigate intrahepatic triglyceride accumulation in Aldob deficiency. Buziau AM; Oosterveer MH; Wouters K; Bos T; Tolan DR; Agius L; Ford BE; Cassiman D; Stehouwer CDA; Schalkwijk CG; Brouwers MCGJ Mol Metab; 2024 Sep; 87():101984. PubMed ID: 38972375 [TBL] [Abstract][Full Text] [Related]
25. Carbohydrate response element binding protein (ChREBP) correlates with colon cancer progression and contributes to cell proliferation. Lei Y; Zhou S; Hu Q; Chen X; Gu J Sci Rep; 2020 Mar; 10(1):4233. PubMed ID: 32144313 [TBL] [Abstract][Full Text] [Related]
26. The absence of hepatic glucose-6 phosphatase/ChREBP couple is incompatible with survival in mice. Rajas F; Dentin R; Cannella Miliano A; Silva M; Raffin M; Levavasseur F; Gautier-Stein A; Postic C; Mithieux G Mol Metab; 2021 Jan; 43():101108. PubMed ID: 33137488 [TBL] [Abstract][Full Text] [Related]
27. Sugar-sweetened beverage intake associations with fasting glucose and insulin concentrations are not modified by selected genetic variants in a ChREBP-FGF21 pathway: a meta-analysis. McKeown NM; Dashti HS; Ma J; Haslam DE; Kiefte-de Jong JC; Smith CE; Tanaka T; Graff M; Lemaitre RN; Rybin D; Sonestedt E; Frazier-Wood AC; Mook-Kanamori DO; Li Y; Wang CA; Leermakers ETM; Mikkilä V; Young KL; Mukamal KJ; Cupples LA; Schulz CA; Chen TA; Li-Gao R; Huang T; Oddy WH; Raitakari O; Rice K; Meigs JB; Ericson U; Steffen LM; Rosendaal FR; Hofman A; Kähönen M; Psaty BM; Brunkwall L; Uitterlinden AG; Viikari J; Siscovick DS; Seppälä I; North KE; Mozaffarian D; Dupuis J; Orho-Melander M; Rich SS; de Mutsert R; Qi L; Pennell CE; Franco OH; Lehtimäki T; Herman MA Diabetologia; 2018 Feb; 61(2):317-330. PubMed ID: 29098321 [TBL] [Abstract][Full Text] [Related]
28. Insights into the Hexose Liver Metabolism-Glucose versus Fructose. Geidl-Flueck B; Gerber PA Nutrients; 2017 Sep; 9(9):. PubMed ID: 28926951 [TBL] [Abstract][Full Text] [Related]
29. Recent progress on the role of ChREBP in glucose and lipid metabolism. Iizuka K Endocr J; 2013; 60(5):543-55. PubMed ID: 23604004 [TBL] [Abstract][Full Text] [Related]
30. Islet ChREBP-β is increased in diabetes and controls ChREBP-α and glucose-induced gene expression via a negative feedback loop. Jing G; Chen J; Xu G; Shalev A Mol Metab; 2016 Dec; 5(12):1208-1215. PubMed ID: 27900263 [TBL] [Abstract][Full Text] [Related]
31. The transcription factor carbohydrate-response element-binding protein (ChREBP): A possible link between metabolic disease and cancer. Iizuka K Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):474-485. PubMed ID: 27919710 [TBL] [Abstract][Full Text] [Related]
33. The Function of MondoA and ChREBP Nutrient-Sensing Factors in Metabolic Disease. Ahn B Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240157 [TBL] [Abstract][Full Text] [Related]
34. Sugar consumption, metabolic disease and obesity: The state of the controversy. Stanhope KL Crit Rev Clin Lab Sci; 2016; 53(1):52-67. PubMed ID: 26376619 [TBL] [Abstract][Full Text] [Related]
35. De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health. Eissing L; Scherer T; Tödter K; Knippschild U; Greve JW; Buurman WA; Pinnschmidt HO; Rensen SS; Wolf AM; Bartelt A; Heeren J; Buettner C; Scheja L Nat Commun; 2013; 4():1528. PubMed ID: 23443556 [TBL] [Abstract][Full Text] [Related]
36. ChREBP plays a pivotal role in the nutrient-mediated regulation of metabolic gene expression in brown adipose tissue. Baek S; Seo DS; Kang J; Ahmad Y; Park S; Joo S; Kim K; Jang Y Life Sci; 2024 Aug; 351():122843. PubMed ID: 38880168 [TBL] [Abstract][Full Text] [Related]
37. Adaptive and maladaptive roles for ChREBP in the liver and pancreatic islets. Katz LS; Baumel-Alterzon S; Scott DK; Herman MA J Biol Chem; 2021; 296():100623. PubMed ID: 33812993 [TBL] [Abstract][Full Text] [Related]
38. Atorvastatin prevents carbohydrate response element binding protein activation in the fructose-fed rat by activating protein kinase A. Rodríguez-Calvo R; Barroso E; Serrano L; Coll T; Sánchez RM; Merlos M; Palomer X; Laguna JC; Vázquez-Carrera M Hepatology; 2009 Jan; 49(1):106-15. PubMed ID: 19053045 [TBL] [Abstract][Full Text] [Related]
40. Tissue Specific Effects of Dietary Carbohydrates and Obesity on ChREBPα and ChREBPβ Expression. Stamatikos AD; da Silva RP; Lewis JT; Douglas DN; Kneteman NM; Jacobs RL; Paton CM Lipids; 2016 Jan; 51(1):95-104. PubMed ID: 26526060 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]